Wird geladen...
The iron chelator deferoxamine decreases myeloma cell survival
OBJECTIVE: This study evaluated serum ferritin (SF) levels and investigated their relationships with various clinical markers in patients with multiple myeloma (MM). Furthermore, the effects and molecular mechanism of deferoxamine (DFO) in myeloma cells were studied. METHODS: Clinical data from 84 p...
Gespeichert in:
| Veröffentlicht in: | J Int Med Res |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
SAGE Publications
2021
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7841871/ https://ncbi.nlm.nih.gov/pubmed/33478296 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0300060520987396 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|